Lubomir Sokol Selected Research

Large Granular Lymphocytic Leukemia

1/2021	Aggressive natural killer cell leukemia: diagnosis, treatment recommendations, and emerging therapies.
10/2013	Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.
5/2012	Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.
4/2012	Tipifarnib-mediated suppression of T-bet-dependent signaling pathways.
12/2008	Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.
10/2007	Large granular lymphocyte leukemia.
4/2007	Diseases of large granular lymphocytes.
4/2005	Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.
8/2003	Large granular lymphocyte leukemia and natural killer cell leukemia/lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lubomir Sokol Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 08/2003
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2018 - 01/2006
11	Lymphoma (Lymphomas) 05/2021 - 08/2003
9	Large Granular Lymphocytic Leukemia 01/2021 - 08/2003
9	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020 - 09/2010
7	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 01/2014
6	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 08/2003
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2017 - 07/2012
5	Hematologic Neoplasms (Hematological Malignancy) 10/2019 - 07/2009
5	Leukemia 01/2018 - 08/2003
5	Infections 10/2017 - 09/2013
4	Mycosis Fungoides 01/2021 - 06/2014
4	Anemia 02/2018 - 11/2007
4	Cytopenia 01/2018 - 08/2003
4	B-Cell Lymphoma (Lymphoma, B Cell) 09/2016 - 07/2012
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016 - 12/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 08/2003
3	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 02/2017
3	Lymphadenopathy 11/2020 - 04/2003
3	Multiple Myeloma 01/2018 - 12/2006
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 08/2014
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2017 - 08/2010
3	Thrombocytopenia (Thrombopenia) 07/2013 - 07/2002
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022 - 11/2017
2	Enteropathy-Associated T-Cell Lymphoma 01/2022 - 11/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 03/2014
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 01/2018
2	Hepatitis B 01/2018 - 02/2017
2	Fever (Fevers) 01/2018 - 07/2013
2	Sepsis (Septicemia) 01/2018 - 04/2003
2	Disease Progression 03/2015 - 08/2003
2	Castleman Disease (Castleman's Disease) 07/2013 - 08/2010
2	Fatigue 07/2013 - 04/2013
2	Bone Marrow Failure Disorders 05/2012 - 02/2011
1	Pathologic Complete Response 05/2021
1	Thromboembolism 10/2019
1	Habitual Abortion (Recurrent Miscarriage) 07/2019
1	Venous Thromboembolism 07/2019
1	Infertility (Sterility) 07/2019
1	Thrombophilia 07/2019
1	Primary Effusion Lymphoma 01/2019
1	Lung Injury 01/2019
1	Extranodal NK-T-Cell Lymphoma 02/2018
1	Polymyositis 01/2018
1	Cellulitis 01/2018
1	Bronchopneumonia 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2018

Drug/Important Bio-Agent (IBA)

9	romidepsin (FK228)FDA Link 10/2019 - 02/2012
7	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2014
7	Lenalidomide (CC 5013)FDA Link 01/2016 - 12/2006
6	Monoclonal AntibodiesIBA 01/2018 - 08/2010
5	Proteins (Proteins, Gene)FDA Link 09/2018 - 04/2005
5	Rituximab (Mabthera)FDA Link 10/2017 - 07/2012
4	Biological ProductsIBA 11/2017 - 08/2003
3	mogamulizumabIBA 01/2022 - 03/2015
3	Vorinostat FDA Link 12/2020 - 01/2018
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 09/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 08/2003
3	Methotrexate (Mexate)FDA LinkGeneric 02/2015 - 08/2003
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 11/2017
2	MethyltransferasesIBA 01/2021 - 01/2021
2	pembrolizumabIBA 01/2020 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2016
2	InflammasomesIBA 09/2018 - 12/2016
2	Antiviral Agents (Antivirals)IBA 01/2018 - 02/2017
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2016 - 03/2016
2	siltuximabIBA 07/2013 - 08/2010
2	MicroRNAs (MicroRNA)IBA 03/2013 - 04/2011
2	Peptides (Polypeptides)IBA 05/2012 - 04/2005
2	EpitopesIBA 05/2012 - 04/2005
2	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2012 - 12/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2006 - 08/2003
1	RNA (Ribonucleic Acid)IBA 01/2022
1	tagraxofuspIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	conatumumabIBA 12/2020
1	Azacitidine (5 Azacytidine)FDA Link 10/2019
1	Oral ContraceptivesIBA 07/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Brentuximab VedotinIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2018
1	PrionsIBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	vasectrin IIIIBA 01/2018
1	AT 61IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	entecavir FDA Link 01/2018

Therapy/Procedure

38	Therapeutics 01/2021 - 04/2003
9	Drug Therapy (Chemotherapy) 01/2022 - 08/2003
6	Cell Transplantation 05/2021 - 11/2017
4	Induction Chemotherapy 01/2019 - 04/2003
3	Immunotherapy 01/2018 - 08/2014
2	Hematopoietic Stem Cell Transplantation 01/2019 - 01/2018
1	Precision Medicine 01/2020
1	Drug Tapering 01/2019